GO:0110090 positive regulation of hippocampal neuron apoptotic process: Neurodegeneration Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0110090 describes any process that activates or increases the frequency, rate or extent of apoptotic cell death specifically in hippocampal neurons.
• Hippocampal neuron apoptosis is a shared endpoint of diabetic encephalopathy, sepsis-associated encephalopathy, and postoperative cognitive dysfunction.
• Key molecular drivers include DAPK1, Netrin-1, HDAC4, MEF2C, SHIP2, S100A8, and BDNF-linked signaling.
• The process is modulated by epigenetic regulation, non-coding RNAs, and inflammatory signaling such as ERK/NF-kB and PI3K/AKT.
• Experimental models range from db/db and sleep-deprivation mice to sepsis and postoperative cognitive dysfunction paradigms.
• CRISPR knockout, point-mutation, knock-in, and overexpression cell models allow causal testing of candidate regulators of this GO term.
Description
GO:0110090, positive regulation of hippocampal neuron apoptotic process, is a biological process term that captures any molecular event that activates or increases the frequency, rate or extent of apoptotic cell death in hippocampal neurons. The hippocampus is a brain region critical for learning and memory, and its progressive neuronal loss is a recurring theme in metabolic, inflammatory, and age-related cognitive disorders. Because apoptosis is a genetically encoded and experimentally tractable form of cell death, this GO term provides a precise framework for linking upstream signaling perturbations to hippocampal neurodegeneration.
positive regulation of hippocampal neuron apoptotic process At A Glance
| GO ID | GO:0110090 |
|---|---|
| GO term | positive regulation of hippocampal neuron apoptotic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increases the frequency, rate or extent of apoptotic cell death in hippocampal neurons |
| Cell type affected | Hippocampal neurons |
| Process type | Positive regulation of a cell death process |
| Disease relevance | Cognitive impairment, diabetic encephalopathy, sepsis-associated encephalopathy, postoperative cognitive dysfunction |
| Experimental readouts | Apoptosis markers, hippocampal histology, behavioral cognition tests |
What Is GO:0110090?
In plain terms, GO:0110090 refers to the set of biological activities that push hippocampal neurons toward apoptosis, rather than merely describing apoptosis itself. It is a positive regulatory term: the annotated process must increase the likelihood, speed, or magnitude of apoptotic death in hippocampal neurons. This distinguishes it from the apoptotic execution machinery and from negative regulators that protect hippocampal neurons. The term is agnostic to the upstream trigger, so it can be applied to metabolic stress, inflammatory cytokines, epigenetic dysregulation, or non-coding RNA networks that converge on hippocampal neuron apoptosis.
Why Is positive regulation of hippocampal neuron apoptotic process Important in Cell Biology?
This GO term matters because hippocampal neuron apoptosis is a convergent pathological endpoint in conditions as diverse as diabetic encephalopathy, sepsis-associated encephalopathy, chronic sleep deprivation, and postoperative cognitive dysfunction. Assigning a candidate gene or pathway to GO:0110090 provides a mechanistic explanation for cognitive decline and a rational target for neuroprotective intervention. It also enables cross-disease comparison, since distinct upstream triggers can be mapped onto the same regulatory process.
• Provides a standardized annotation for genes that promote hippocampal neuron death.
• Links metabolic disease such as diabetes to hippocampal neurodegeneration.
• Connects systemic inflammation and sepsis to hippocampal apoptosis.
• Explains cognitive decline in chronic sleep deprivation models.
• Supports mechanistic studies of postoperative cognitive dysfunction.
• Highlights epigenetic and non-coding RNA control of neuronal survival.
• Offers a framework for testing neuroprotective interventions in vivo.
• Enables CRISPR-based causal validation of candidate regulators.
• Facilitates biomarker discovery for cognitive impairment.
• Bridges molecular neuroscience and translational neurology.
What Happens During positive regulation of hippocampal neuron apoptotic process?
Initiation by upstream stress signals
In simple terms: Something goes wrong in or around the neuron, and that stress starts the death program.
Positive regulation of hippocampal neuron apoptosis begins when metabolic, inflammatory, or epigenetic stress activates upstream signaling. In diabetic encephalopathy, epigenetic regulation of DAPK1 and Netrin-1 drives the process. In sepsis-associated encephalopathy, oxidative stress and ERK/NF-kB signaling in microglia and astrocytes contribute to the inflammatory environment that promotes neuronal apoptosis. Chronic sleep deprivation similarly activates microglial pathways that can influence hippocampal neuron survival.
Mitochondrial and kinase signaling amplification
In simple terms: The cell's stress sensors amplify the death signal inside the neuron.
Once initiated, intracellular kinase and phosphatase networks amplify the apoptotic signal. SHIP2 negatively regulates insulin/IGF-I actions that are implicated in neuroprotection and memory function in mouse brain, so loss of this brake can favor hippocampal neuron apoptosis. DAPK1 is a death-associated kinase whose epigenetic upregulation is linked to diabetic encephalopathy. These signaling nodes represent points where positive regulation of the apoptotic process can be experimentally manipulated.
Epigenetic and non-coding RNA control
In simple terms: Chemical marks on DNA and small RNA molecules can turn the death program up or down.
Epigenetic regulation of DAPK1 and Netrin-1 drives diabetic encephalopathy, showing that DNA methylation or chromatin changes can positively regulate hippocampal neuron apoptosis. Non-coding RNAs also participate: the MALAT1/miR-382-3p/BDNF axis is regulated by aerobic exercise in type 2 diabetes and influences cognitive impairment, while the circAKT3/miR-106a-5p/HDAC4/MEF2C axis stabilizes a feedback cycle in hippocampi of aged mice with postoperative cognitive dysfunction. These examples illustrate that positive regulation can be encoded at the RNA level.
Inflammatory and glial contribution
In simple terms: Immune cells in the brain can release signals that push neurons toward death.
Microglia and astrocytes are active participants in the regulatory process. Orexin-A attenuates the inflammatory response in sepsis-associated encephalopathy by modulating oxidative stress and inhibiting ERK/NF-kB signaling in microglia and astrocytes. S100A8 knockdown activates PI3K/AKT signaling to inhibit microglial autophagy and improve cognitive impairment mediated by chronic sleep deprivation. Necroptosis and neuroinflammation have also been linked to cognitive decline in cerebral small vessel disease models. These findings show that positive regulation of hippocampal neuron apoptosis is not neuron-autonomous but involves glial crosstalk.
Execution and cognitive consequence
In simple terms: The neuron dies, and because the hippocampus is needed for memory, cognition suffers.
When the positive regulatory signals overwhelm survival pathways, hippocampal neurons undergo apoptotic execution. The functional consequence is cognitive impairment, as documented in diabetic, septic, sleep-deprived, and postoperative models. Aerobic exercise improves cognitive impairment in type 2 diabetes by regulating the MALAT1/miR-382-3p/BDNF pathway in serum exosomes, indicating that the process is modifiable. SHIP2 regulation of insulin/IGF-I actions further links neuroprotection to memory function.
Key Genes Involved in GO:0110090 positive regulation of hippocampal neuron apoptotic process
The following genes and proteins have been experimentally linked to regulation of hippocampal neuron apoptosis or to closely related cognitive phenotypes in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DAPK1 | Death-associated protein kinase 1; epigenetic regulation drives diabetic encephalopathy | Epigenetic regulator of hippocampal neuron apoptosis |
| Netrin-1 | Axon guidance and survival cue; epigenetically regulated in diabetic encephalopathy | Survival factor whose dysregulation favors apoptosis |
| HDAC4 | Histone deacetylase 4; part of circAKT3/miR-106a-5p/HDAC4/MEF2C axis | Epigenetic modifier in postoperative cognitive dysfunction |
| MEF2C | Transcription factor in the HDAC4/MEF2C feedback cycle | Downstream effector of hippocampal dysfunction |
| SHIP2 | Inositol phosphatase that negatively regulates insulin/IGF-I actions | Neuroprotection and memory function |
| S100A8 | Inflammatory calcium-binding protein; knockdown activates PI3K/AKT | Microglial autophagy and cognitive impairment |
| BDNF | Neurotrophic factor supporting neuronal survival and plasticity | Target of MALAT1/miR-382-3p axis in diabetes |
| MALAT1 | Long non-coding RNA regulating miR-382-3p/BDNF | Exercise-responsive regulator of cognition |
| miR-382-3p | MicroRNA targeting BDNF pathway | Serum exosome cargo in type 2 diabetes |
| circAKT3 | Circular RNA stabilizing miR-106a-5p/HDAC4/MEF2C axis | Protective factor in aged hippocampus |
| miR-106a-5p | MicroRNA in circAKT3 feedback cycle | Postoperative cognitive dysfunction |
| ERK | Mitogen-activated protein kinase in inflammatory signaling | Modulated by Orexin-A in sepsis |
| NF-kB | Transcription factor driving inflammatory gene expression | Inhibited by Orexin-A in microglia and astrocytes |
| PI3K | Phosphoinositide 3-kinase survival pathway | Activated by S100A8 knockdown |
| AKT | Serine/threonine kinase promoting cell survival | Downstream of PI3K in microglial autophagy |
| Orexin-A | Neuropeptide modulating inflammation and oxidative stress | Attenuates sepsis-associated encephalopathy |
How Is positive regulation of hippocampal neuron apoptotic process Regulated?
The process is regulated at multiple levels. Epigenetic control of DAPK1 and Netrin-1 drives diabetic encephalopathy. Non-coding RNA circuits, including MALAT1/miR-382-3p/BDNF and circAKT3/miR-106a-5p/HDAC4/MEF2C, provide post-transcriptional regulation. Inflammatory kinase cascades such as ERK/NF-kB and PI3K/AKT modulate the survival-death balance. SHIP2 acts as a negative regulator of insulin/IGF-I neuroprotective signaling. Together, these layers determine whether hippocampal neurons survive or enter apoptosis.
positive regulation of hippocampal neuron apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DAPK1 | Diabetic encephalopathy | db/db mouse hippocampus; CRISPR knockout in hippocampal neurons |
| Netrin-1 | Diabetic encephalopathy | Epigenetic editing or overexpression in neuronal cultures |
| HDAC4 | Postoperative cognitive dysfunction | Aged mouse hippocampus; circAKT3 knockdown |
| S100A8 | Chronic sleep deprivation cognitive impairment | Sleep-deprivation mouse model; microglial knockdown |
| SHIP2 | Insulin/IGF-I neuroprotection and memory | SHIP2 knockout or knockdown in mouse brain |
Diabetic encephalopathy and metabolic cognitive decline
Epigenetic regulation of DAPK1 and Netrin-1 drives diabetic encephalopathy, directly linking positive regulation of hippocampal neuron apoptosis to metabolic disease. Aerobic exercise improves cognitive impairment in type 2 diabetes by regulating the MALAT1/miR-382-3p/BDNF signaling pathway in serum exosomes, showing that the process is modifiable. SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain, further connecting metabolic signaling to hippocampal survival.
Sepsis-associated encephalopathy
Orexin-A attenuates the inflammatory response in sepsis-associated encephalopathy by modulating oxidative stress and inhibiting ERK/NF-kB signaling in microglia and astrocytes. This indicates that inflammatory glial activation can positively regulate hippocampal neuron apoptosis and that targeting this pathway may preserve cognition during sepsis.
Postoperative cognitive dysfunction and aging
CircAKT3 alleviates postoperative cognitive dysfunction by stabilizing the feedback cycle of miR-106a-5p/HDAC4/MEF2C in hippocampi of aged mice. This provides a direct example of a non-coding RNA circuit that restrains positive regulation of hippocampal neuron apoptosis in an age-related surgical context.
Sleep deprivation and cerebral small vessel disease
S100A8 knockdown activates PI3K/AKT signaling to inhibit microglial autophagy and improve cognitive impairment mediated by chronic sleep deprivation. Necroptosis and neuroinflammation have also been implicated in cognitive decline associated with cerebral small vessel disease in db/db mice. These studies broaden the disease relevance of hippocampal neuron apoptosis regulation.
From positive regulation of hippocampal neuron apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene necessary for hippocampal neuron apoptosis? | CRISPR knockout in hippocampal neuron cultures or mouse hippocampus |
| Does a specific phosphorylation site control the apoptotic function? | Point-mutation knock-in of phospho-dead or phospho-mimetic residues |
| Does a disease-associated variant alter apoptotic regulation? | Knock-in of the patient variant in neuronal cell lines |
| Where is the protein expressed in hippocampal neurons? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a survival factor reduce apoptosis? | Overexpression cell model or viral delivery in hippocampus |
| Which pathways cooperate to regulate apoptosis? | CRISPR library screening in hippocampal neuron models |
How to Study the positive regulation of hippocampal neuron apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V / caspase-3 assay | Apoptotic cell death | Quantifying hippocampal neuron apoptosis |
| TUNEL staining | DNA fragmentation | Histological detection of apoptosis in hippocampus |
| RNA sequencing | Transcriptome changes | Identifying upstream regulators |
| Methylation profiling | Epigenetic marks | DAPK1 and Netrin-1 regulation |
| Morris water maze | Spatial learning and memory | Cognitive outcome in mouse models |
| Immunofluorescence | Protein localization and cell identity | Neuron vs glia contribution |
| Western blot | Protein expression and cleavage | Cleaved caspase-3, signaling kinases |
| CRISPR library screening | Gene requirement at scale | Discovering novel regulators of apoptosis |
Apoptosis assays in hippocampal neurons
Apoptosis can be measured by Annexin V staining, caspase-3/7 activity assays, TUNEL staining, and cleaved caspase-3 immunoblotting. These readouts directly quantify the endpoint of GO:0110090 and are used in diabetic, septic, and sleep-deprivation models.
Transcriptomic and epigenetic profiling
RNA sequencing and methylation or chromatin immunoprecipitation studies can identify upstream regulators such as DAPK1 and Netrin-1 whose epigenetic changes drive diabetic encephalopathy. Non-coding RNA profiling can reveal circuits such as MALAT1/miR-382-3p/BDNF and circAKT3/miR-106a-5p/HDAC4/MEF2C.
Behavioral and cognitive testing
Morris water maze, Y-maze, and novel object recognition tests assess the cognitive consequence of hippocampal neuron apoptosis. These are used in type 2 diabetes, sepsis, sleep deprivation, and postoperative cognitive dysfunction models.
Imaging and histology
Immunofluorescence and confocal imaging of hippocampal sections can visualize neuronal loss, glial activation, and apoptotic markers. Co-staining with neuronal and glial markers helps distinguish neuron-autonomous from glia-mediated regulation.
How CRISPR Can Be Used to Study GO:0110090 positive regulation of hippocampal neuron apoptotic process
Knockout
CRISPR knockout of candidate genes such as DAPK1, SHIP2, or S100A8 in hippocampal neuron cultures or mouse models can test whether the gene is necessary for positive regulation of hippocampal neuron apoptosis. Loss-of-function studies are the most direct way to establish causality for GO:0110090.
Point Mutation
Point-mutation knock-in can dissect specific residues required for apoptotic regulation, for example phosphorylation sites in DAPK1 or SHIP2. This approach distinguishes catalytic activity from scaffolding functions and can model patient variants.
Knock-in
Knock-in of reporters or disease-associated alleles allows tracking of gene expression and function in hippocampal neurons. Tagged knock-in of Netrin-1 or BDNF can reveal localization and secretion dynamics relevant to neuronal survival.
Overexpression
Overexpression of protective factors such as circAKT3, BDNF, or Orexin-A can test whether increasing their levels reduces hippocampal neuron apoptosis and improves cognition. Overexpression models complement knockout studies by demonstrating sufficiency.
How EDITGENE Supports positive regulation of hippocampal neuron apoptotic process Research
Researchers studying positive regulation of hippocampal neuron apoptotic process-related genes often need to determine whether a candidate gene is causally involved in neuronal death or is merely a bystander. EDITGENE provides CRISPR-based cell and animal model services that enable precise, reproducible testing of such hypotheses.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of hippocampal neuron apoptotic process research.
Frequently Asked Questions About positive regulation of hippocampal neuron apoptotic process
What is GO:0110090?
GO:0110090 is the Gene Ontology term for positive regulation of hippocampal neuron apoptotic process, meaning any process that increases the frequency, rate or extent of apoptotic death in hippocampal neurons.
What genes are involved in positive regulation of hippocampal neuron apoptotic process?
Genes experimentally linked to this process include DAPK1, Netrin-1, HDAC4, MEF2C, SHIP2, S100A8, BDNF, MALAT1, circAKT3, and miR-106a-5p.
How is hippocampal neuron apoptosis regulated in diabetes?
Epigenetic regulation of DAPK1 and Netrin-1 drives diabetic encephalopathy, and the MALAT1/miR-382-3p/BDNF pathway is modifiable by aerobic exercise.
Does inflammation promote hippocampal neuron apoptosis?
Yes, inflammatory signaling such as ERK/NF-kB in microglia and astrocytes contributes to sepsis-associated encephalopathy, and Orexin-A attenuates this response.
What role does S100A8 play in cognitive impairment?
S100A8 knockdown activates PI3K/AKT signaling, inhibits microglial autophagy, and improves cognitive impairment mediated by chronic sleep deprivation.
How can I study GO:0110090 in the lab?
Common methods include Annexin V and caspase-3 assays, TUNEL staining, RNA sequencing, methylation profiling, behavioral tests, and CRISPR knockout or overexpression models.
What is the role of SHIP2 in hippocampal neuroprotection?
SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.
Can non-coding RNAs regulate hippocampal neuron apoptosis?
Yes, MALAT1/miR-382-3p/BDNF and circAKT3/miR-106a-5p/HDAC4/MEF2C circuits regulate hippocampal function and cognitive outcomes.
What diseases are associated with hippocampal neuron apoptosis?
Diabetic encephalopathy, sepsis-associated encephalopathy, postoperative cognitive dysfunction, chronic sleep deprivation cognitive impairment, and cerebral small vessel disease have all been linked.
How does EDITGENE support research on this GO term?
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services to test causal roles of candidate genes in hippocampal neuron apoptosis.
Conclusion
GO:0110090 provides a precise, experimentally tractable definition of the processes that drive hippocampal neuron apoptosis. The cited literature shows that this process is controlled by epigenetic, non-coding RNA, inflammatory, and metabolic signaling layers and is causally linked to cognitive impairment in multiple disease contexts. CRISPR-based models offer a rigorous path to identify which regulators are necessary or sufficient, accelerating the development of neuroprotective strategies.
References
- 1. Bateman RM et al.. 2016. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.. Crit Care 20(Suppl 2):94 PMID: 27885969
- 2. Zhou Y et al.. 2025. Epigenetic Regulation of DAPK1 and Netrin-1 Drives Diabetic Encephalopathy.. Adv Sci (Weinh) 12(37):e02535 PMID: 40787892
- 3. Guo J et al.. 2024. Orexin-A Attenuates the Inflammatory Response in Sepsis-Associated Encephalopathy by Modulating Oxidative Stress and Inhibiting the ERK/NF-κB Signaling Pathway in Microglia and Astrocytes.. CNS Neurosci Ther 30(11):e70096 PMID: 39508266
- 4. Wang DQ et al.. 2025. Role of Necroptosis and Neuroinflammation in CSVD-Associated Cognitive Decline in db/db Mice.. FASEB J 39(18):e70868 PMID: 40981684
- 5. Wang M et al.. 2023. Aerobic exercise improves cognitive impairment in mice with type 2 diabetes by regulating the MALAT1/miR-382-3p/BDNF signaling pathway in serum-exosomes.. Mol Med 29(1):130 PMID: 37740187
- 6. Wang X et al.. 2024. CircAKT3 alleviates postoperative cognitive dysfunction by stabilizing the feedback cycle of miR-106a-5p/HDAC4/MEF2C axis in hippocampi of aged mice.. Cell Mol Life Sci 81(1):138 PMID: 38478029
- 7. Soeda Y et al.. 2010. The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.. Mol Endocrinol 24(10):1965-77 PMID: 20829391
- 8. Xiong Y et al.. 2024. S100A8 knockdown activates the PI3K/AKT signaling pathway to inhibit microglial autophagy and improve cognitive impairment mediated by chronic sleep deprivation.. Int Immunopharmacol 143(Pt 2):113375 PMID: 39418730
